Mahendran et al.
JOCArticle
for 1 min, in which the concentration of each sample was
0.42 mg/mL. Finally, 50 μL of the solution was injected into the
HPLC autosampler and quantitated by the absorption signal at
254 nm. The solubilities of elemental S8, 5A-C, or 6A-F were
determined by adding 10-50 μL aliquots of methanol or water to
1-3 mg of the compounds. The solutions were vortexed for 2 min
and then stirred 10-15 min at rt. Polysulfane decompositions
were also conducted in the presence of sodium hydroxide. To a
solution of polysulfanes 6A-F (2.5 mM) and internal standard,
acetanilide (0.25 mM), was added NaOH (0.625, 1.25, 1.875, or
2.5 mM) in 0.1 mL of methanol. After certain periods of time, the
reaction was analyzed by HPLC by injecting 15 μL of the sample.
Sulfur Transfer and Trapping Studies. Trapping studies were
carried out in 0.2 mL of benzene solution. To a solution of
PEGylated benzopenthasulfanes 6A-F (2.3 mM) and norbor-
nene or 2,3-dimethylbutadiene (2.3 mM) was added ethanethiol
(2.3 mM). The reaction mixture was vortexed for 2 min and
analyzed by GC-MS by injecting 1 μL of the sample. Both scan
and single ion mode (SIM) analyses were conducted on the sample.
Cell Proliferation Assays. The cell lines were grown from
frozen stocks originally obtained from the American Type
Culture Collection. The prostate cancer cell lines PC3 and
DU145 cells were grown in F12K and DMEM, respectively.
MDA-MB-231 breast cancer cells were grown in DMEM. All
the media were supplemented with 10% FBS and penicillin/
streptomycin. Cell proliferation was assessed by a cell prolifera-
tion assay as previously described.34 Briefly, equal numbers of
cells were distributed in 96-well plates and the cells were
incubated at 37 °C in a 5% CO2 incubator until they were in log
phase growth. The medium was removed and replaced with a
growth medium containing the sulfur-containing compounds
(0-30 μM). After 48 h incubation, the media was removed, and
the plates were frozen at -80 °C. The assay was performed by
warming the plates to rt and followed by the addition of the
reagent to the wells. The fluorescence was measured with a plate
reader (excitation/emission, 485/530 nm).
The cytotoxicity assay was conducted as follows: Cells were
cultured in RPMI-1640 medium with 10% fetal bovine serum and
penicillin-streptomycin (100 U/mL and 100 μg/mL, respectively)
and maintained in a 37 °C humidified 5% CO2 incubator. On the
day before the drug treatment, cells were plated onto each well of
the 96-well plate at 2,000 cells/well (200 μL of the medium per well).
After 24 h, cells were treated with different concentrations of the
sulfur-containing compounds and incubated for 72 h. After the
incubation, cell growth was evaluated using a 96-titer solution cell
proliferation assay. UV absorption (490 nm) of each well was
quantified with a microplate reader.
N-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)benzo[d][1,2,3]trithiole-
5-carboxamide (6A). HPLC (150 mm ꢀ 3.9 mm C18 column,
90% acetonitrile in water, flow rate 1 mL/min): tR=20.3 min.
LCMS: tR = 4.6 min; HRMS (þESI) calcd for C14H19NO4S3 =
361.0476, found 361.0478.
with saturated aqueous NaHCO3 solution (3 ꢀ 30 mL), 1 M HCl
(3 ꢀ 30 mL), and water (3 ꢀ 30 mL). The organic solvent was evap-
orated and the crude product was chromatographed (CHCl3/
MeOH, 10:1) to yield 9.6 mg of 6C (93% purity): Rf = 0.57, 1H
NMR (CDCl3, 400 MHz) δ 8.30 (d, J=1.9 Hz, 1H), 7.89 (d, J=8.0
Hz, 1H), 7.78 (dd, J=7.90, 1.9 Hz, 1H), 7.18 (br s, 1H), 3.66 (m,
10H), 3.54 (m, 2H), 3.32 (s, 3H); 13C NMR (CDCl3, 100 MHz) δ
162.4, 155.2, 150.3, 145.8, 1145.0, 137.3, 136.3, 131.5, 130.2, 125.4,
122.5. HPLC (150 mm ꢀ 3.9 mm C18 column, 90% acetonitrile in
water, flow rate 1 mL/min): tR=28.7 min. LCMS: tR = 6.5 min;
HRMS (þESI) calcd for C14H19NO4S5 =424.9918, found
424.9926.
N-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)benzo[g][1,2,3,4,5,6]-
hexathiocine-8-carboxamide (6D). HPLC (150 mm ꢀ 3.9 mm
C18 column, acetonitrile/water 1:9 to 9:1 over 53 min, flow rate
at 1 mL/min): tR=30.0 min. LCMS: tR=7.1 min; HRMS (þESI)
calcd for C14H19NO4S6=456.9638, found 456.9636.
N-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)benzo[h][1,2,3,4,5,6,7]-
heptathionine-9-carboxamide (6E). HPLC (150 mm ꢀ 3.9 mm
C18 column, acetonitrile/water 1:9 to 9:1 over 53 min, flow rate
at 1 mL/min): tR = 36.0 min. LCMS: tR = 7.8 min; HRMS
(þESI) calcd for C14H19NO4S7 = 488.9359, found 488.9354.
N-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)benzo[j][1,2,3,4,5,6,7,
8,9]nonathiacyclo-undecine-11-carboxamide (6F). HPLC (150 mm ꢀ
3.9 mm C18 column, acetonitrile/water 1:9 to 9:1 over 53 min,
flow rate 1 mL/min): tR = 40.8 min. LCMS: tR = 9.2 min; HRMS
(þESI) calcd for C14H19NO4S9 = 552.8800, found 552.8788. The
identification of peak 6F at 9.2 min in the spectrum is complicated
because the former is a shoulder in the chromatogram of 3A. Peak
6F has been assigned on the basis of the extracted ion chromato-
gram feature of the software.
Methyl 3,4-Dihydroxybenzoate (8). Yield 1.018 g (76%). 3,4-
Dihydroxybenzoic acid 7 (1.0 g, 6.49 mmol) was dissolved in
40 mL of MeOH. A catalytic amount of concentrated HCl
(5 drops) was added to the methanol solution, which was then
refluxed overnight at 80 °C. Water (300 mL) was added, and the
mixture extracted with EtOAc/hexane (60:40) and dried over
anhydrous MgSO4. The solvent was removed, affording a light
1
brown solid (mp 137-139 °C). H NMR (acetone-d6) δ 3.81 (s,
3H), 6.90 (d, J = 8.3 Hz, 1H), 7.45 (dd, J = 8.3, 2.0 Hz, 1H), 7.50
(d, J = 2.0 Hz, 1H), 8.47 (br s, 2H); 13C NMR (acetone-d6) δ 51.9,
115.8, 117.2, 123.0, 123.4, 145.6, 150.8, 167.1; HRMS (þESI) calcd
for C8H8O4 = 168.0423, found 168.0423.
Methyl 3,4-Bis[(dimethylamino carbothioyl)oxy]benzoate (9).
Yield 0.546 g (74%). Methyl-3,4-dihydroxybenzoate 8 (738 mg,
4.39 mmol), DABCO (17.6 mmol), and N,N-dimethylthio-
carbamoyl chloride (2.17 g, 17.6 mmol) were stirred in DMF
(10 mL) for 30 min. The white solid that formed was dissolved in
50 mL of water. The product was extracted with EtOAc (3 ꢀ
30 mL) and dried over anhydrous MgSO4. The solvent was
removed, affording a yellow-green oil. Benzoate 9 was obtained
by flash chromatography (EtOAc/hexanes, 2:3); Rf = 0.4 or via
recrystallization in 95% EtOH as white crystals (mp 110-
N-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)benzo[e][1,2,3,4]tetra-
thiine-6-carboxamide (6B). HPLC (150 mm ꢀ 3.9 mm C18
1
112 °C). H NMR (CDCl3) δ 8.01 (dd, J = 8.4, 2.0 Hz, 1H),
column, 90% acetonitrile in water, flow rate 1 mL/min): tR =
22.6 min. LCMS: tR=5.6 min; HRMS (þESI) calcd for C14H19-
7.85 (d, J = 2.0, 1H), 7.25 (d, J = 8.4, 1H), 3.90 (s, 3H), 3.43 (s,
3H), 3.30 (s, 6H); 13C NMR (CDCl3) δ 186.6, 186.1, 165.6,
149.4, 145.6, 128.7, 128.1, 125.9, 124.4, 52.3, 43.4, 43.3, 38.9,
38.8; HRMS (þESI) calcd for C14H18O4S2N2 calcd 342.0708,
found 342.0708. (lit. data for 9, ref 14); 1H NMR (CDCl3) δ 8.00
(dd, J = 8.5, J = 2.0 Hz, 1H), 7.86 (d, J = 2.0 Hz, 1H), 7.25 (d,
J = 8.5 Hz, 1H), 3.90 (s, 3H), 3.43, 3.42, 3.30, 3.29, 3.30 (4 ꢀ br s,
4 ꢀ 3H); 13C NMR (CDCl3) δ 186.4, 186.0, 165.6, 149.3, 145.5,
128.7, 128.2, 125.9, 124.4, 52.3, 43.4, 43.3, 38.9.
NO4S4 = 393.0197, found 393.0193.
N-(2-(2-(2-Methoxyethoxy)ethoxy)ethyl)benzo[f][1,2,3,4,5]-
pentathiepine-7-carboxamide (6C). Yield 9.6 mg (53%). A solu-
tion of 3,6,9-trioxadecylamine 15 (13.8 mg, 0.0847 mmol) in 1.5 mL
of THF was added to a solution of 4-nitrophenyl benzo[f]-
[1,2,3,4,5]pentathiepine-7-carboxylate 14 (17 mg, 0.0423 mmol) in
2.5 mL of THF. The reaction mixture was stirred under argon
atmosphere overnight. The solvent was evaporated, and the residue
was dissolved in 30 mL of CH2Cl2. The organic layer was washed
Methyl 2-Oxo-1,3-benzodithiole-5-carboxylate (10). Yield
0.079 g (40%). Methyl 3,4-bis([dimethylamino-carbothioyl]-
oxy)benzoate 9 (300 mg, 0.876 mmol) was heated at 240 °C in
10 mL of diphenyl ether for 30 min. The reaction mixture was
purified by flash chromatography using a gradient of EtOAc/
(34) Bittman, R.; Li, Z.; Samadder, P.; Arthur, G. Cancer Lett. 2007, 251,
53–58.
5556 J. Org. Chem. Vol. 75, No. 16, 2010